Selectis Health (GBCS) Invested Capital (2011 - 2025)

Selectis Health has disclosed Invested Capital across 15 years of filings, most recently posting $7.2 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $7.2 million, down 47.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.2 million (down 47.55% YoY), and the FY2025 annual result was $7.2 million, down 47.55% from the prior year.
• Invested Capital came in at $7.2 million for Q4 2025 at Selectis Health, down from $12.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $22.2 million in Q4 2023 to a low of $1.4 million in Q3 2023.
• The 5-year median for Invested Capital is $7.7 million (2024), against an average of $9.0 million.
• Across the five-year window, Invested Capital tumbled 90.57% in 2021 and jumped 583.54% in 2023, its largest moves.
• Selectis Health's Invested Capital stood at $9.4 million in 2021, then plunged by 65.48% to $3.2 million in 2022, then surged by 583.54% to $22.2 million in 2023, then tumbled by 38.22% to $13.7 million in 2024, then plunged by 47.55% to $7.2 million in 2025.
• The last three Invested Capital figures came in at $7.2 million (Q4 2025), $12.9 million (Q3 2025), and $12.3 million (Q2 2025), per Business Quant data.